 |
|
Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication
Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu
Clin Mol Hepatol. 2024;30(3):326-344. Published online 2024 Apr 26 DOI: https://doi.org/10.3350/cmh.2024.0155
|
|
Citations to this article as recorded by
 Meeting the challenges of HCC post SVR in the Post-DAA Era: A Path Forward
Seren M. Gedallovich, Paul Y. Kwo
Clinical and Molecular Hepatology.2024;[Epub] CrossRef
|